← Back to all trials
Active Not Recruiting
NCT06476938
Testing Gene PilotLX With Latinx Cancer Patients
Conditions: Cancer
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 239
Sponsor: Fox Chase Cancer Center
Location: MD Anderson Cancer Center at Cooper Camden New Jersey
Summary
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Eligibility Criteria
Inclusion Criteria:
Self-identified Latinx patients who:
1. diagnosed with solid tumor cancers
2. speak/read English or Spanish;
3. can provide informed consent.
Exclusion Criteria:
Patients with hematologic/liquid cancers (leukemia, lymphoma, multiple myeloma, etc.)
Source: ClinicalTrials.gov (NCT06476938). StuddyBuddy aggregates publicly available trial information.
